# Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer

> **NCT06787170** · — · COMPLETED · sponsor: **The First People's Hospital of Yunnan** · enrollment: 1129 (actual)

## Conditions studied

- High-grade Serous Ovarian Cancer (HGSOC)

## Interventions

- **DIAGNOSTIC_TEST:** MRI habitat imaging

## Key facts

- **NCT ID:** NCT06787170
- **Lead sponsor:** The First People's Hospital of Yunnan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-05-31
- **Target enrollment:** 1129 (ACTUAL)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06787170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06787170, "Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06787170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*